Cardiac Surgery
ACCP Guideline | Perioperative management of antithrombotic therapy.
1 Nov, 2022 | 12:18h | UTCExecutive Summary: Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline – CHEST
Commentary on Twitter
2022 guideline for perioperative management of VKAs, heparin bridging, DOACs & antiplatelets
Pts requiring elective surgery, in general,🛑💊 before surgery
👉VKAs 3-5d
👉DOACS 1-2d
👉P2Y12 receptor inhibitors 3-7d✅drug specificshttps://t.co/RYNrEOovRe @SCCM_Surgery @SCCM_CPP— Lauren R. Sorce, PhD, RN, CPNP-AC/PC, FAAN, FCCM (@SCCMPresident) August 26, 2022
M-A of RCT | Analgesic efficacy and risk of low-to-medium dose intrathecal morphine in patients undergoing cardiac surgery.
25 Oct, 2022 | 13:10h | UTC
Clinical practice update for management of acute kidney injury associated with cardiac surgery.
20 Oct, 2022 | 12:31h | UTCSociety of Cardiovascular Anesthesiologists Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery – Anesthesia & Analgesia (free for a limited period)
Commentary on Twitter
The @scahq Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery https://t.co/miFP5MkbnL @iars360
Potential renoprotective benefit:
❤️Goal-directed oxygen delivery on CPB
❤️KDIGO
❤️The use of vasopressin in vasoplegic shock pic.twitter.com/S9O2RtIhIr— Anesthesia&Analgesia (@IARS_Journals) October 13, 2022
Cohort Study | Association of thoracic aortic aneurysm size with long-term patient outcomes.
6 Oct, 2022 | 13:47h | UTCAssociation of Thoracic Aortic Aneurysm Size With Long-term Patient Outcomes: The KP-TAA Study – JAMA Cardiology (free for a limited period)
Commentary on Twitter
Risk of dissection is low for non-syndromic pts with ascending aortic aneurysm. Risk higher w larger size, but with a 6.0cm inflection point, early surgery for Pts <5.5 cm should be selective, as the risks from aortic surgery may outweigh the benefits. https://t.co/Mgf1TtHkzr
— JAMA Cardiology (@JAMACardio) October 5, 2022
Current updates in acute traumatic aortic injury: radiologic diagnosis and management.
30 Sep, 2022 | 12:36h | UTC
Review | Regional anesthesia and acute perioperative pain management in thoracic surgery.
30 Sep, 2022 | 12:32h | UTC
Opinion | Tranexamic acid for safer surgery: the time is now.
7 Sep, 2022 | 12:37h | UTCTranexamic acid for safer surgery: the time is now – British Journal of Surgery
Related:
Update on applications and limitations of perioperative tranexamic acid.
JCS 2022 Guideline on management and re-interventional therapy in patients with congenital heart disease in the long-term after the initial repair.
2 Sep, 2022 | 13:10h | UTC
Review | Invasive and noninvasive cardiovascular monitoring options for cardiac surgery.
30 Aug, 2022 | 12:03h | UTCInvasive and noninvasive cardiovascular monitoring options for cardiac surgery – JTCVS Open
Consensus statement on the management of preoperative anemia and iron deficiency in adult cardiac surgery patients.
19 Aug, 2022 | 16:10h | UTC
M-A | Association of dual antiplatelet therapy with ticagrelor with vein graft failure after coronary artery bypass graft surgery.
10 Aug, 2022 | 15:32h | UTCAssociation of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis – JAMA (free for a limited period)
Editorial: Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery – JAMA (free for a limited period)
Author Interview: Coronary Artery Bypass Surgery in 2022 – JAMA
News Release: Two-medication strategy offers both benefit and risk after coronary artery bypass surgery – Weill Cornell Medicine
M-A | The outcome of post-cardiotomy extracorporeal membrane oxygenation in neonates and pediatric patients.
4 Aug, 2022 | 13:48h | UTC
M-A | Perioperative care bundles for the prevention of surgical-site infections.
2 Aug, 2022 | 12:30h | UTC
RCT | In patients at risk for antithrombin deficiency after cardiac surgery, preoperative antithrombin supplementation did not result in better outcomes.
2 Aug, 2022 | 11:39h | UTCA Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Antithrombin Supplementation in Patients at Risk for Antithrombin Deficiency After Cardiac Surgery – Anesthesia & Analgesia (link to abstract – $ for full-text)
M-A | Negative-pressure wound therapy for prevention of sternal wound infection after adult cardiac surgery.
28 Jul, 2022 | 13:03h | UTC
RCT | Effect of high- vs. low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery.
27 Jul, 2022 | 12:21h | UTCEffect of High- vs Low-Dose Tranexamic Acid Infusion on Need for Red Blood Cell Transfusion and Adverse Events in Patients Undergoing Cardiac Surgery: The OPTIMAL Randomized Clinical Trial – JAMA (free for a limited period)
Commentary on Twitter
https://twitter.com/JAMA_current/status/1551960541488451586
RCT | External support for saphenous vein grafts in coronary artery bypass surgery.
26 Jul, 2022 | 11:44h | UTCExternal Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial – JAMA Cardiology (link to abstract – $ for full-text)
Commentary on Twitter
This RCT found that the 12-month difference in intimal hyperplasia area between supported and unsupported grafts did not achieve statistical significance, after accounting for early graft occlusions. https://t.co/Qrx3QsmdLc
— JAMA Cardiology (@JAMACardio) July 4, 2022
RCT | In patients undergoing cardiac surgery with cardiopulmonary bypass, using a 4% albumin solution for volume expansion did not reduce adverse events compared to ringer acetate.
21 Jul, 2022 | 13:32h | UTCEffect of 4% Albumin Solution vs Ringer Acetate on Major Adverse Events in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Albumin vs Crystalloid Fluid for Resuscitation in Cardiac Surgery: New Evidence and Arguments in the Timeless Debate – JAMA (free for a limited period)
Commentary: Trial does not support albumin as primer, volume replacement solution in CABG – Healio (free registration required)
Commentary on Twitter
https://twitter.com/JAMA_current/status/1549424077298868225
Review | Temporary mechanical circulatory support: devices, outcomes, and future directions.
14 Jul, 2022 | 12:23h | UTC
Cohort Study | Aneurysm growth, survival, and quality of life in untreated thoracic aortic aneurysms.
12 Jul, 2022 | 12:26h | UTCCommentary: Growth, Survival, Quality of Life in Untreated Thoracic Aortic Aneurysms – American College of Cardiology
Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome.
7 Jul, 2022 | 12:38h | UTC
Registry-based cohort study | Interventions in adults with repaired coarctation of the aorta.
7 Jul, 2022 | 12:29h | UTC
M-A: Patent ductus arteriosus stent vs. surgical aortopulmonary shunt for initial palliation of cyanotic congenital heart disease with ductal‐dependent pulmonary blood flow.
30 Jun, 2022 | 11:00h | UTC
RCT: Prothrombin complex concentrate vs. plasma for post–cardiopulmonary bypass coagulopathy and bleeding.
30 Jun, 2022 | 10:50h | UTCProthrombin Complex Concentrate vs Plasma for Post–Cardiopulmonary Bypass Coagulopathy and Bleeding: A Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Commentary on Twitter
https://twitter.com/JAMASurgery/status/1542176079728738305
RCT: Effect of nitric oxide via cardiopulmonary bypass on ventilator-free days in young children undergoing congenital heart disease surgery.
28 Jun, 2022 | 10:55h | UTCEffect of Nitric Oxide via Cardiopulmonary Bypass on Ventilator-Free Days in Young Children Undergoing Congenital Heart Disease Surgery: The NITRIC Randomized Clinical Trial – JAMA (free for a limited period)
News Release: Nitric oxide does not improve babies’ recovery after heart surgery – University of Zurich
Commentary on Twitter
In this randomized clinical trial, among infants undergoing heart surgery, delivery of nitric oxide into the cardiopulmonary bypass did not increase ventilator-free survival at 28 days. https://t.co/VJzBLPOP6U
— JAMA (@JAMA_current) June 27, 2022